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Dendrimeric nanoparticles for two-photon photodynamic therapy 
and imaging: synthesis, photophysical properties, 
innocuousness in daylight and cytotoxicity under two-photon 
irradiation in the NIR 
Aude Sourdon,[a] Magali Gary-Bobo,[c] Marie Maynadier,[c] Marcel Garcia,[c] Jean-Pierre Majoral,[d,e] 
Anne-Marie Caminade,[d,e] Olivier Mongin*[a] and Mireille Blanchard-Desce*[b] 
Abstract: The synthesis and the photophysical properties of a new 
class of fully organic monodisperse nanoparticles for combined two-
photon imaging and photodynamic therapy are described. The 
design of such nanoparticle is based on the covalent immobilization 
of a dedicated quadrupolar dye - which combine large two-photon 
absorbing (2PA) properties, fluorescence and singlet oxygen 
generation ability - in a phosphorous-based dendrimeric architecture. 
Firstly, a bifunctional quadrupolar dye bearing two different grafting 
moieties, a phenol function and an aldehyde function, was 
synthesized. It was then covalently grafted through its phenol 
function to a phosphorus-based dendrimer scaffold of generation 1. 
The remaining aldehyde functions were then used to carry on the 
dendrimer synthesis up to generation 2 introducing finally at its 
periphery 24 water-solubilizing triethyleneglycol chains. A dendrimer 
confining 12 photoactive quadrupolar units in its inner scaffold and 
showing water solubility was thus obtained. Interestingly, the G1 and 
G2 dendrimers retain some fluorescence as well as significant 
singlet oxygen production efficiencies while they were found to show 
very high 2PA cross-sections in a broad range of the NIR biological 
spectral window. Hydrophilic dendrimer G2 was tested in vitro on 
breast cancer cells, first in one- and two-photon microscopy, which 
allowed for visualization of their cell internalization, then in two-
photon photodynamic therapy. While being non-toxic in the dark and, 
more importantly, under daylight exposition, dendrimer G2 proved to 
be very efficient cell death inducer only under two-photon irradiation 
in the NIR. 
Introduction 
Photodynamic therapy (PDT) is a clinical treatment used in 
oncology for the treatment of certain types of tumors including 
esophagus, skin, bladder and non-small cell lung carcinomas, as 
well as in ophthalmology for the treatment of age-related 
macular degeneration (ARMD).[1] PDT is based on the activation 
by light of photosensitizers; non-toxic in the absence of light 
excitation, a photosensitizer is able upon excitation by a laser 
source, to generate singlet oxygen and/or other reactive oxygen 
species (ROS), which leads to the destruction of the targeted 
tissues.[2] 
The use of a two-photon excitation (2PE) offers several 
advantages for PDT, especially for the treatment of small areas, 
such as small solid tumors.[3] These include the intrinsic three-
dimensional resolution allowed by 2PE, offering the ability for 
highly spatially resolved excitation as well as increasing 
penetration depth in tissues thanks to the use of near infra-red 
(NIR) light.[4] Yet, in order to achieve efficient treatments, 
optimized 2P photosensitizers (2PP) - i.e., combining very large 
2PA cross-sections in the biological spectral window (700-1000 
nm) and high singlet oxygen (or ROS production) quantum 
yields - are required. In addition, if the 2PP remains fluorescent, 
in vitro monitoring is allowed, paving the way to theranostics 
applications.[3] Most of the current clinical or preclinical 
photosensitizers are porphyrin derivatives, such as porfimer 
sodium (Photofrin) and verteporfin (Visudyne). As model 
tetraphenylporphyrin (TPP, 12 GM),[5] these compounds exhibit 
high singlet oxygen quantum yields, significant fluorescence but 
low 2PA cross sections (10 GM and 50 GM, respectively) in the 
near infra-red (NIR).[6] Giant 2PA cross-sections have been 
obtained with expanded porphyrins,[7] conjugated porphyrin 
dimers, trimers and oligomers,[8] planarized fused or bridged 
porphyrins[9] and supramolecular assemblies,[8a, 10] however at 
the expense of a strong modification of the other photophysical 
properties. In particular, it often leads to decrease or 
suppression of fluorescence and onset of residual one-photon 
absorption (1PA) overlapping with the 2PA band located in the 
NIR region. The huge gain in 2PA response therefore results in 
the loss of some of the intrinsic advantages of selective 2PA, in 
particular of the 3D confinement of excitation and therefore 
spatial resolution in laser-assisted tumor resection. 
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To increase the 2PA cross-sections (while avoiding one-photon 
absorption at the same wavelength) and still retain the excellent 
photosensitization and luminescence properties of the 
porphyrins, different systems have been designed, such as 
symmetrically or dissymmetrically -extended phosphorescent 
metalloporphyrins,[11] as well as dendritic antenna systems 
based on resonant energy transfer (FRET) from peripheral 2P 
absorbers towards a single porphyrin core,[12] and “semi-
disconnected” assemblies with a weak conjugation between 2P 
absorbing dendrons and a porphyrin core,[13] or between a 
central 2PA unit and peripheral porphyrins.[14] FRET between 2P 
absorbers and porphyrinic photosensitizers could also be 
achieved without covalent architectures by coencapsulating 
them within silica nanoparticles.[15] Other types of nanoparticles 
based on energy transfer have been designed, including 
quantum dot-porphyrin[16] and quantum dot-phthalocyanine[17] 
conjugates and porphyrin-doped conjugated polymers.[18] 
Non-porphyrinic 2P absorbing photosensitizers have also been 
developed,[19] among which should be mentioned quadrupolar 
chromophores substituted with heavy atoms such as bromine or 
iodine,[20] which leads to efficient intersystem crossing and 
singlet oxygen generation quantum yields but concomitantly to 
vanishing fluorescence. We have previously developed 
alternative 2P fluorescent photosensitizers based on banana-
shaped quadrupolar systems, that combine large 2PA cross-
sections and significant singlet oxygen quantum yields, while 
maintaining fair fluorescence quantum yields.[21] These 
symmetric photosensitizers were covalently incorporated within 
mesoporous silica nanoparticles for efficient two-photon 
photodynamic therapy of solid tumors.[4e, 4f] 
As an alternative to these hard nanoparticles, our aim was to 
develop soft and monodisperse fully organic nanodots by 
gathering quadrupolar 2P photosensitizers in phosphorus-based 
dendrimer architectures, and to graft at their surface water-
solubilizing groups. Among the major advantages of 
phosphorus-based dendrimers[22] are their low toxicity[23] and 
their accessibility for both inner and surface functionalization 
using covalent chemistry. 
This highly modular “organic nanodots” strategy was previously 
used successfully to obtain covalent assemblies of fluorophores, 
leading to luminescent nanoparticles that can outperform 
semiconductor quantum dots in terms of one- and two-photon 
brightness.[24] These fluorescent nanodots have been proved to 
be of major interest for in vivo imaging.[25] 
We report here the first two-photon photosensitizing nanodots 
and their use in photodynamic therapy. 
Results and Discussion 
Synthesis of the graftable two-photon photosensitizer 
The photosensitizer needed for the synthesis of 2-G2 (Fig 1) 
should exhibit two different orthogonal grafting moieties, a 
phenol function to attach it to the dendrimeric scaffold, and an 
aldehyde function to continue the dendrimer synthesis and 
introduce water-solubilizing peripheral groups. The synthesis of 
this dissymmetric photosensitizer is described in Scheme 1. 
Figure 1. Molecular design. 
The Mitsunobu condensation of N-ethyl-N-hydroxyethylaniline 
(1) with hydroquinone afforded 2a. Phosphonium salts 2b and 6 
were synthesized according to the procedures reported.[26] Wittig 
condensations of 5-iodo-2-thiophenecarboxaldehyde (3)[27] with 
phosphonium salts 2b and 6 led to mixtures of stereoisomers. 
Their isomerization with iodine afforded 4a and 7a, respectively, 
as pure trans isomers (Scheme 1). 
  
Scheme 1. Reagents and conditions. a) hydroquinone, PPh3, DIAD, THF, RT, 
16h (36%); b) PPh3, paraformaldehyde, toluene, NaI, H2O, acetic acid, 66h, 
61°C, (83% for 6 and 84% for 2b); c) 3, tBuOK, anhyd CH2Cl2, RT, 16h (50% 
for 7a and 54% for 4a); d) acetyl chloride, DMAP, Et3N/CH2Cl2, RT, 16h (97%); 
e) Pd(PPh3)2Cl2, CuI, ethynyltrimethylsilane, Et3N/toluene, 40°C, 16h (87% for
8 and 94% for 5); f) 4 hydroxybenzaldehyde, PPh3, DIAD, THF, RT, 16h 
(81%); g) 8, 9, Pd(PPh3)2Cl2, CuI, TBAF/THF, 40°C, 16h (77%); h) 5, 
Pd(PPh3)2Cl2, CuI, TBAF/THF, 40°C, 16h (70%); i) NaOH, EtOH/THF, RT, 20 
min (84%). 
Ac
ce
pt
ed
 M
an
us
cr
ip
t
FULL PAPER 
Scheme 2. Synthesis of spherical dendrimer 2-G1. 
On one hand, the phenol function of 4a was esterified with acetyl 
chloride, giving 4b, which was reacted with 
ethynyltrimethylsilane in a Sonogashira coupling to afford 5, and 
on the other hand, Mitsunobu condensation of 7a with 4-
hydroxybenzaldehyde gave 7b, which was also coupled with 
ethynyltrimethylsilane, leading to 8. Finally, graftable 
chromophore 10 was obtained as a single E,E-stereoisomer, 
from 9,9-dibutyl-2,7-diiodo-9H-fluorene (9)[28] by means of two 
successive Sonogashira couplings with 8 and 5, followed by 
saponification of the acetate protective group (Scheme 1). 
The synthesis of the spherical first generation dendrimer 2-G1 
was carried out by grafting 12 equivalents of the 2PA 
chromophore 10 in the presence of caesium carbonate, to the 
P(S)Cl2 end groups of the first generation phosphorous 
dendrimer 1-G1,[22a, 29] built from a cyclotriphosphazene core[30] 
(Scheme 2). The substitution of the twelve chlorine atoms of 1-
G1 with such a bulky substituent was slow and needed 7 days to 
go to completion. This reaction was monitored by 31P NMR 
which shows a total disappearance of the singlet at δ = 62.3 
ppm corresponding to the phosphorus P1 in 1-G1 on behalf of a 
new singlet at δ = 64.3 ppm due to the phosphorus P1 in 2-G1. 
An intermediate signal observed at δ = 69.3 ppm and 
corresponding to the monosubstitution (i.e. P(S)ClOAr) totally 
disappears when the reaction is over. The second step 
consisted in the condensation of 12 equivalents of the 
phosphorhydrazide 11 with the aldehyde functions of 2-G1 in 
chloroform at room temperature, and afforded the second 
generation of the dendrimer 1-G2 (Scheme 3). 
Scheme 3. Synthesis of spherical dendrimer 2-G2. 
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Table 1. Photophysical properties of compound 10, 2-G1 and 2-G2 in THF. 
Cpd 
λabs 
/nm 
εmax[a] 
/M-1.cm-1 
εmax/n[b] 
/M-1.cm-1 
λem 
/nm 
Stokes shift  
/103 cm-1 
 F [c]  /ns [d]  [e] 
10 434 1.2 105 1.2 105 544 4.66 0.51 1.3 0.16 
2-G1 433 1.2 106 1.0 105 547 4.81 0.50 
1= 0.56 ;n1=63 % 
2=1.5; n2=37 % 
0.10 
2-G2 434 1.0 106 8.3 104 560 5.18 0.21 
1= 0.52 ;n1=66 % 
2=1.4; n2=34 % 
0.07 
[a] Molar extinction coefficient. [b] Molar extinction coefficient per chromophoric subunit [c]F = fluorescence quantum yield, using as a standard 
quinine bisulfate (F= 0.546) in 0.5M aq H2SO4. [d] Fluorescence lifetime. [e] = singlet oxygen formation quantum yield determined relative to 
tetraphenylporphyrin in methylene chloride ([TPP] = 0.60 in methylene chloride). 
The reaction was monitored by 1H NMR, its completion being 
characterized by the total disappearance of the aldehyde singlet. 
The 31P NMR spectrum of 2- G1 consists of three singlets δ = 8.6 
ppm for the core, δ = 63.3 ppm for P1, δ = 64.4 ppm for the newly 
grafted phosphorus P2. 
The next step involved the grafting of 24 equivalents of the 
monodisperse triethyleneglycol chain 12 on 1-G2 to improve 
solubility in water, affording dendrimer 2-G2 (Scheme 3). Here 
again, the reaction was monitored by 31P NMR. Almost no 
change occurs for the signal corresponding to the core, but we 
observed the total disappearance of the singlet at δ = 63.4 ppm 
corresponding to the phosphorus P2 in 2-G1 on behalf of a new 
singlet, slightly deshielded. An overlap occurs for the signals of 
phosphorus P1 and P2 at δ = 64.6 ppm. To ascertain the full 
substitution or condensation, we used in all cases a slight 
excess of reagents (10%), which was relatively easy to eliminate 
by washings. 
One photon absorption (1PA) and fluorescence properties 
The compared photophysical properties of 10, 2-G1, and 2-G2 in 
THF are shown in Table 1 and their absorption and emission 
spectra are represented in Fig 2. THF was chosen as a common 
solvent as all three compounds are soluble in this solvent. All 
compounds exhibit an intense absorption band from the near UV 
to the blue visible range and an emission band from the green 
visible range to the yellow visible range (Fig 2). Dendrimers also 
show strong one-photon absorption in the UV. 
The low-energy absorption band located at 434 nm can be 
ascribed to a periphery-to-core intramolecular charge transfer 
transition, characteristic of bis-donor quadrupolar dyes built from 
a fluorene core.[31] We note a broadening on the high energy 
side for organic nanodots 2-G1 and even more for 2-G2 as 
compared to the isolated dye 10 in solution (Fig.2). This can be 
related to the residual absorption of the dendrimeric backbone. 
In addition, a hypochromic effect is observed: the extinction 
coefficients of the chromophoric building blocks are reduced by 
about 17 % for 2-G1 and 30% for 2-G2 (Table 1). 
This suggests that different conformations or relative positioning 
of the dyes within the dendrimeric architecture might occur, in 
particular in the case of 2-G2, suggesting that partial interactions 
and more compact arrangement might occur in that case. 
 
Figure 2. Normalized absorption and emission spectra of compounds 10, 2-G1 
and 2-G2, in THF. 
Dye 10 exhibits a significant singlet oxygen quantum yield as 
well as a reasonable fluorescence quantum yield (Table 1), as 
was initially required for allowing both therapy (by 
photosensitized production of singlet oxygen) and monitoring (by 
fluorescence imaging). 
The grafting of photosensitizers on the dendrimeric scaffold 
(from 10 to 2-G1) leads to a slight red shift and broadening of the 
emission (Fig 2), in relation with an increase of the polarity 
produced by polarizable environment produced by the 
dendrimeric scaffold and the closeness of adjacent quadrupolar 
dyes.[32] Interestingly, in spite of the confinement of the dyes 
chromophores in a reduced volume, 2-G1 maintains the same 
fluorescence quantum yield than the isolated dye 10. This 
indicates that no significant through-space interchromophoric 
interactions which would lead to fluorescence quenching occurs 
within 2-G1. At opposite, fluorescence quenching of fluorescence 
is often observed when widespread fluorescent dyes (such as 
Nile red, dioxaborine…) are grafted in close proximity onto a 
similar dendritic architecture.[33] In contrast, rigid extended 
dendrimers where quadrupolar subunits are directly connected 
by triphenylamine nodes were reported to show strong through-
bond coupling leading to cooperative enhancement of 2PA and 
preservation of high fluorescence quantum yield.[34] In 
comparison, the design of dendrimers 2-G1 and 2-G2 does not 
allow through-bond coupling between dye subunits due to the 
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presence of alkyl linkers (CH2-CH2) between conjugated 
moieties. 
We also note that the fluorescence decay is biexponential most 
probably in relation with conformational flexibility of the dye. 
Such phenomenon was not observed in the case of ultra-bright 
organic nanodots confining more rigid and shorter quadrupolar 
dyes.[24a] 
A more pronounced red shift of the emission band is observed 
with 2-G2, indicating that the addition of a water-solubilizing layer 
increases the polarity of the environment of the buried 
chromophores. The most prominent feature is a significant 
decrease of the fluorescence quantum yield. This behavior 
indicates that competing deactivation process takes place and/or 
interaction between the dyes occurs within dendrimer 2-G2 
compared to 2-G1. Most probably, the presence of the 
hydrophilic layer created by the TEG surface moieties produces 
a different external environment which may induce different 
organization of the dendritic backbone, as discussed earlier, and 
favor interchromophoric ground-state interactions that are 
deleterious to fluorescence. 
The singlet oxygen production () is also reduced in 
dendrimers 2-G1 (by 37 %) and 2-G2 (by 56%) as compared to 
isolated dye 10. We note that this progression is similar to the 
decrease in extinction coefficient and could be related to the 
different conformations and possible interactions of the dyes 
within the dendrimeric backbone. This may also originate from 
the hindered access of dissolved dioxygen molecules to the 
buried dyes subunits in dendrimer 2-G2, the TEG surface 
moieties creating a barrier to the diffusion of O2 molecules. 
Solvatochromism 
Fig 3 and 4 illustrate the dependence of the absorption and 
emission properties of dye 10 and soft organic nanodot 2-G2 on 
solvent polarity. Increasing the solvent polarity induces a slight 
red shift of the absorption band and a marked bathochromic shift 
of the emission band as clearly illustrated in Fig 3 for 10 and Fig 
4 for 2-G2. This is consistent with symmetry breaking occurring 
in the excited state prior to emission.[35] 
Figure 3. Normalized absorption and emission spectra of quadrupolar dye 10 
in solvents of different polarities. 
Figure 4. Normalized absorption and emission of dendrimer 2-G2 in solvents 
of different polarities. 
However, it appears clearly that the emission of nanodot 2-G2 in 
a low polarity solvent such as toluene is strongly red-shifted in 
comparison with the emission of 10 in the same solvent, which 
confirms that the dendrimeric scaffold and the triethyleneglycol 
chains do influence the polarity of the environment of the 
chromophores by creating a cybotactic region reminiscent of that 
of ethyl acetate. 
Two-photon absorption 
2PA measurements were conducted by investigating the two-
photon excited fluorescence (2PEF) of dendrimers 2-G1 and 2-
G2 in THF. The 2PA spectrum of monomeric dye 10 was also 
determined for comparison. The quadratic dependence of the 
2PEF signal on the excitation intensity was checked for each 
data point, indicating that no photodegradation or saturation 
occurs. 
As expected from its symmetric quadrupolar type structure, dye 10 
shows an intense 2PA band located around 720 nm (with 
maximum 2PA cross-section of about 1900 GM) which can be 
ascribed to a higher energy excited state which is strongly two-
photon allowed  (see figure S2). Yet the lowest-energy excited 
state also leads to significant 2PA response at 870 nm (Table 2), 
indicating that this state is both one-photon and two-photon 
allowed. This effect can be attributed to a breaking of 
centrosymmetry induced by the dissymmetrical environment of the 
dye. Indeed, dye 10 bears an alkoxybenzaldehyde moiety only on 
one side. The presence of this dipolar unit (> 5 D)[36] generates a 
local electric field which in turns affects the polarization of the 
quadrupole thus breaking its centrosymmetry. This effect is clearly 
noticeable, in agreement with the reported strong effect of local 
electric field on the 2PA of dyes.[37] Along this line, we also note 
that the two-photon allowed excited state is also slightly one-
photon allowed (see Figure S2). Hence the breaking of 
centrosymmetry results in multiple absorption bands (and thus 
broader response) as compared to purely symmetrical 
quadrupolar chromophores. 
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Table 2. Two-photon absorption data of compounds 10, 2-G1, 2-G2 in THF. 
Cpd 
21PAmax 
/nm 
2 
/GM [a] 
2/n 
/GM 
2PAmax1 
/nm [b] 
2max1 
/GM [c] 
2max1/n 
/GM 
2PAmax2 
/nm [b] 
2max2 
/GM [c] 
2max2/n 
/GM 
2F 
/GM[d]
2 
/GM[e]
10 868 680 680 820 1240 1240 720 1890 1890 960 300 
2-G1 866 6050 504 820 11200 933 730 19200 1517 9600 1920 
2-G2 868 4700 392 820 8160 680 730 13200 1100 2770 920 
[a] 2PA cross section at 21PAmax. [b] Maximum 2PA wavelength. [c] 2PA cross section at 2PAmax. [d] 2P-brightness at 2PAmax2. [e] Figure of merit of the 2P-
induced singlet oxygen generation at2PAmax2 .1 GM = 10 -50 cm4.s.photon-1. 
Figure 5. 2PA spectra of 10, 2-G1, 2-G2 in THF (with solid curves as guides for 
the eyes only). 
Dendrimers 2-G1 and 2-G2 also show the same intense 2PA 
bands located at 820 and 730 nm as clearly seen from Fig. 5, 
leading to very large 2PA responses at 730 nm (up to 19200 GM 
for 2-G1 and 13200 GM for 2-G2,). Yet, we note that the molecular 
response of each individual dye is affected by the confinement 
and the modification of the environment induced by the 
dendrimeric scaffold (see Figure S1). As seen from Table 2, a 
reduction of the 2PA cross-sections per chromophoric subunit of 
about 20-25 % (resp. 40-45 %) is observed at 870 nm, 820 nm 
and 730 nm for 2-G1 (resp. 2-G2). Addition of the water-solubilizing 
groups leads to a further decrease of about 30% of the 2PA cross-
sections for dendrimer 2-G2 as compared to 2-G1. 
This decrease is reminiscent of the decrease noted in one-photon 
absorption, although the trend is even stronger. This once again 
confirms that different positioning and possibly partial ground-state 
interactions between dye subunits occur in the dendrimeric 
architecture, leading to both decrease of 1PA and 2PA. 
Yet we note that dendrimers 2-G1 and 2-G2 retain very large 2PA 
cross-sections at 730 nm (19200 and 13200 GM respectively) and 
maintain high 2PA response over 5000 GM down to 900 nm. This 
effect can be ascribed to symmetry breaking (also noted in 
dendrimers 2-G1 and 2-G2, see Figure S3 and S4) promoted by 
the presence of dipolar moieties in close proximity. This results in 
a broadening of the 2PA spectrum, which is of interest for 
biological applications and use in two-photon bioimaging. 
Investigation of cell internalization by fluorescence imaging 
Based on its properties (1PA and 2PA responses, fluorescence 
properties and presence of water-solubilizing surface groups), 
dendrimer 2-G2 was tested in one- and two-photon excited 
fluorescence (2PEF) cell imaging. In order to analyze its 
penetration in cancer cells, dendrimer 2-G2 was incubated for 
24 h with MCF-7 human breast cancer cells, whose nuclei were 
stained with Hoechst 33342 as described in the experimental 
section. As shown in Figure 6, confocal fluorescence microscopy 
showed that 2-G2 is efficiently internalized.  
Figure 6. Nuclear marker (left, excited at 405nm), 2-G2 (middle, excited at 458 nm) and merge (right) confocal microscopy images of living MCF-7 human breast 
cancer cells, incubated for 24 h with 50 µg.mL-1  2-G2. 
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Figure 7. Merged multiphoton confocal microscopy images of living MCF-7 
breast cancer cells, incubated for 3 h at 37°C with 50 µg.mL-1 2-G2 excited at 
750 nm (green) and membrane marker (yellow). 
The cell distribution of dendrimer 2-G2 was also investigated by 
co-staining with a membrane marker. MCF-7 breast cancer cells 
were incubated for 3 h with 2-G2, then plasma membranes were 
stained with CellMask as described in the experimental section 
(Fig 7). Merged images of membranes and 2-G2 showed that 
NDs were efficiently internalized after 3 h of incubation. The 
semi-circular shape of NDs localization in cell suggests that 2-G2 
molecules are located in lysosomes. 
Hence, 2-G2 is internalized by cancer cells. The amount of 
internalized dendrimers depends on the incubation time. We 
found that more dendrimers were present in cells after 24 h 
incubation (Fig 6) than after 3 h (Fig 7). 
In all cases, internalization occurs and 2-G2 was found to be 
nontoxic at 50 µg.mL-1 without irradiation (not shown). An 
incubation time of 20 h was thus selected for PDT experiments. 
Figure 8. 2PE-PDT efficiency on MCF-7 breast cancer cells incubated or not 
(control) for 20 h with 50 g. mL-1 of dendrimer 2-G2 and then irradiated or not 
(control) at 760 nm for 3×1.57 s. Data are mean ± SD of 3 experiments. 
Two-photon excited photodynamic therapy (2PE-PDT) 
experiments 
2PE-PDT experiments were performed on MCF-7 breast cancer 
cells incubated with or without 2-G2 (50 g. mL-1) for 20 hours. 
After incubation, cells were washed, maintained in fresh culture 
medium and then submitted or not to laser irradiation. Two-
photon irradiation was performed on a confocal microscope 
equipped with a femtosecond pulsed Ti:sapphire laser. The laser 
beam was focused using a microscope objective lens (10X, NA 
0.4). Cells were irradiated at 760 nm by 3 scans of 1.57 sec 
each at an average power of 80 mW. The surface of the 
scanned areas was 1.5 x 1.5 mm2 (mean energy of 16.6 J cm-2). 
Two days after irradiation, the percentage of living cells was 
determined by MTS enzymatic assay. Results are reported in 
Figure 8, and 2-G2 was found to be non-toxic without irradiation. 
It was also shown that irradiation alone did not damage the cells. 
Hence, the photodynamic therapeutic potential of 2-G2 is 
demonstrated, with 78% cell death under two-photon irradiation 
of MCF-7 cells incubated with 2-G2. The in vitro efficiency of this 
compound is thus comparable to that of mesoporous silica 
nanoparticles (MSNs) incorporating a closely related 
chromophore towards the same MCF-7 cell line, these MSNs 
leading to 56% cell death after 4 h incubation time and 100% 
cell death after 24 h incubation time, followed by irradiation (3 x 
1 s) at the same wavelength and power.[4e] As these MSNs had 
also been demonstrated to induce tumor regression (70% 
decrease in tumor size) on nude mice bearing tumor xenografts 
upon 9 min of irradiation at the same wavelength (i.e. 760nm) 
and power, a required irradiation time of 10-20 min can be 
anticipated with organic dendrimer 2-G2 for in vivo 2PE-PDT. It 
should be added that 2PE-PDT drugs bearing peptides specific 
of tumor vasculature targeting, already led to even higher tumor 
regressions for deep-tissue cancer treatment on mice, with 
comparable irradiation times.[4c, 4j] This indicates that further 
surface functionalization of dendrimer 2-G2 with similar targeting 
peptides would be of major interest for PDT. 
Figure 9. Absence of toxicity on MCF-7 breast cancer cells of 2-G2 in the dark 
(right) or under daylight exposition (left). 
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The two-photon induced toxicity of 2-G2 can originate from 
different processes including singlet oxygen production. Indeed 
2-G2 displays a two-photon induced singlet oxygen generation 
(2), which is 120 times larger than that of TPP (see Table 2). 
Yet formation of reactive oxygen species via different photo-
induced processes (in particular electron transfer sensitized by 
quadrupolar subunits, which become strong electron donor in 
the excited state) may also contribute to the two-photon induced 
cell death. 
Interestingly, no cell death was observed when the cells were 
exposed to daylight for 4 hours, indicating that dendrimer 2-G2 is 
nontoxic under daylight illumination conditions (Figure 9). 
Dendrimer 2-G2 is thus nontoxic in the dark and even under 
daylight exposition. This represents an important progress in 
view of therapeutics as it allows circumventing side effects in 
current daylight. The daylight toxicity represents a common 
drawback of photodynamic therapy medical treatment as it 
requires patients to avoid direct light for a certain time. This 
effect can be related to the large number of UV absorbers 
present on the outskirt of the phosphorous dendritic backbone of 
2-G2, which form an effective UV-screen, avoiding excitation of 
the inner quadrupolar photosensitizers by UV from sunlight. At 
opposite, these constitutive UV absorbers are very poor 2P 
absorbers in the 700-950 nm spectral range, thus permitting 2P 
excitation of the inner quadrupolar subunits. This leads to a two-
photon versus one-photon excitation on-off process (i.e. the 
dendritic platform is transparent to two-photon excitation in the 
NIR region but absorbing upon UV excitation). 
Conclusions 
In summary we have described a new class of dendrimeric 
nanoparticles for theranostics, which combine unique properties 
for bioimaging and anticancer therapy. These fully organic, soft, 
yet monodisperse nanoparticles show: 
(i) high two-photon absorption in the biological spectral window, 
which allows highly confined and three-dimensional photo-
addressing in tissues, thus limiting side damages, 
(ii) large two-photon brightness, which allows fluorescent 
tracking in cells and investigation of cell internalization, 
(iii) efficient two-photon photosensitizing properties in the NIR 
region leading to highly spatially controlled cell death. 
In vitro experiments conducted on human breast cancer cells 
demonstrated these dendrimeric nanoparticles to be efficient 
nanomedicine tools as their distribution and penetration within 
cells can be efficiently monitored by fluorescence imaging, while 
cancer cell death can be induced efficiently and selectively upon 
two-photon excitation in the NIR. 
Moreover they were found to be non-toxic in the dark and, more 
importantly, under daylight exposition, which is a major 
advantage in comparison with other photodynamic therapy 
medical treatments. The grafting of targeting functions could 
further improve the therapeutic promise of these nano-objects by 
adding to the spatial selectivity of the two-photon activation a 
high affinity for cancer cells. We are currently exploring this way. 
Experimental Section 
Synthetic procedures 
General methods. All air or water-sensitive reactions were carried out 
under dry argon. Solvents were generally dried and distilled prior to use. 
Reactions were monitored by thin layer chromatography on Merck silica 
gel 60 F254 precoated aluminum sheets, or by NMR. Column 
chromatography: Merck silica gel Si 60 (40-63 m, 230-400 mesh or 63-
200 m, 70-230 mesh). Melting points were determined on a system 
Kofler type WME. NMR: Bruker Avance AV 300 (1H: 300.13 MHz, 13C: 
75.48 MHz, 31P: 121.58 MHz), in CDCl3, CD2Cl2 or DMSO-d6 solutions; 
1H chemical shifts () are given in ppm relative to TMS as internal 
standard, J values in Hz and 13C chemical shifts relative to the central 
peak of CDCl3 at 77.0 ppm, 31P chemical shifts relative to 85% H3PO4. 
High and low resolution mass spectra measurements were performed at 
the Centre Regional de Mesures Physiques de l'Ouest (C.R.M.P.O, 
Rennes) using a Micromass MS/MS ZABSpec TOF instrument with EBE 
TOF geometry; LSIMS (Liquid Secondary on Ion Mass Spectrometry) at 
8 kV with Cs+ in m-nitrobenzyl alcohol (mNBA); ES+ (electrospray 
ionization, positive mode) at 4 kV; EI (electron ionization) at 70 eV. 
Elemental analyses were performed at C.R.M.P.O. 
5-Iodo-2-thiophenecarboxaldehyde (3). A mixture of 2-
thiophenecarboxaldehyde (1.79 g, 15.92 mmol), iodine (2.00 g, 7.96 
mmol) in carbon tetrachloride (4 mL), iodic acid (0.70 g, 3.98 mmol), 
distilled water (3 mL), acetic acid (8 mL) and concentrated sulfuric acid 
(0.12 mL) were stirred under reflux for 1h and at room temperature for 
another 12h. After washing with 2% NaHCO3 and Na2S2O3 the organic 
layer was dried over anhydrous MgSO4 and the solvent was removed in 
vacuum. The crude product was purified by column chromatography 
eluting with ethyl acetate/ heptane (1:9) to yield 2.95 g (78%) of 3 as 
yellowish crystals, mp 53 °C; 1H NMR (CDCl3): 9.8 (s, 1H), 7.4 (s, 2H). 
13C NMR (CDCl3): 181.1, 149.6, 138.2, 137.0, 87.8. 
2-(Ethyl-[4-[2-(5-iodothiophen-2-yl)vinyl]phenyl]amino)ethanol (7a). 
Air was removed from a mixture of 3 (1.95 g, 8.19 mmol), phosphonium 
salt 6 (6.32 g, 12.29 mmol) and tBuOK (1.84 g, 16.38 mmol) by bubbling 
with argon for 20 min. Fresh distilled CH2Cl2 (50 mL) was added. The 
solution was stirred at room temperature for 16 h. It was then filtered 
through a short pad of silica gel. The solvent was removed under 
reduced pressure, and the crude product was purified by column 
chromatography eluting with CH2Cl2/ AcOEt (98:2 to 92:8) to yield 2.16 g 
of a mixture of Z/E stereoisomers. To 1.34 g of this mixture of isomers 
dissolved in Et2O (50 mL) was added a solution of iodine in Et2O (1 g.L-1, 
3.4 mL). The mixture was then stirred 21h at room temperature under 
light. After washing with sat Na2S2O3, the organic layer was dried over 
anhydrous MgSO4 and the solvent was removed in vacuum to yield 1.02 
g (50%) of 7a as yellow crystals. M.p: 93 °C. 1H NMR (CDCl3): 7.3 (d, J= 
8.8 Hz, 2H), 7.1 (d, J=3.7 Hz, 1H), 6.9 (d, J= 16 Hz, 1H), 6.78 (d, J=16 
Hz, 1H), 6.74 (d, J=8.8 Hz, 2H), 6.6 (d,J=3.7 Hz, 1H), 3.8 (q, 2H), 3.5 (m, 
4H), 1.6 (t, J= 5.8 Hz, 1H), 1.2 (t, J= 7 Hz, 3H). 13C NMR (CDCl3): 149.7, 
147.7, 137.2, 129.1, 127.5, 125.6, 124.7, 116.5, 112.3, 70.2, 60.0, 52.2, 
45.4, 11.8. 
4-[2-(Ethyl-[4-[2-(5-iodothiophen-2-yl)vinyl]phenyl]amino)ethoxy]-
benzaldehyde (7b). Under argon, a mixture of 7a (0.5 g, 1.25 mmol), 4-
hydroxybenzaldehyde (0.31 g, 2.51 mmol) and triphenylphosphine (0.66 
g, 2.51 mmol) was dissolved in THF (15 mL) and bubbled with argon for 
20 min. A solution of DIAD (0.5 mL, 2.51 mmol) in THF (3 mL) was then 
added dropwise and the mixture was stirred overnight at room 
temperature. The solvent was removed in reduce pressure and the crude 
product was purified on column chromatography with CH2Cl2 to yield 0.51 
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g (81%) of yellow crystals. M.p: 108 °C. 1H NMR (CDCl3) 9.9 (s, 1H), 7.8 
(d, J= 8.8 Hz, 2H), 7.3 (d, J= 8.8 Hz, 2H), 7.1 (d, J= 3.7 Hz, 1H), 7.0 (d, 
J= 8.7, 2H), 6.9 (d, J= 15,5 Hz, 1H), 6.78 (d, J= 16 Hz, 1H), 6.72 (d, J= 
8.9 Hz, 2H), 6.65 (d, J=3.7 Hz, 1H), 4.2 (t, J= 6 Hz, 2H), 3.8 (t, J= 5.9 Hz, 
2H), 3.5 (q, 2H), 1.3 (t, J= 7 Hz, 3H). 13C NMR (CDCl3): 190.7, 163.6, 
147.2, 145.6, 133.4, 131.9, 130.19, 130.16, 129.5, 127.9, 124.3, 120.2, 
117.1, 114.7, 111.9, 99.4, 98.2, 65.8, 49.5, 45.8, 12.3. 
4-[2-(Ethyl-[4-[2-(5-trimethylsilanylethynylthiophen-2-yl)vinyl] -
phenyl]amino)ethoxy]benzaldehyde (8): Air was removed from the 
solution of 7b (0.77 g, 1.54 mmol) dissolved in toluene (15 mL) and Et3N 
(3 mL) by bubbling with argon for 20 min. After heating at 40 °C, CuI (6 
mg, 0.03 mmol), Pd(PPh3)2Cl2 (22 mg, 0.03 mmol) and 
ethynyltrimethylsilane (0.33 mL, 2.31 mmol) were added. The mixture 
was stirred at 40 °C overnight. Solvent was removed by reduce pressure 
and the crude product was purified by column chromatography with 
CH2Cl2/ Heptane (6:4 to 7:3) to yield 0.63 g (87%) of 8. 1H NMR (CDCl3): 
9.9 (s, 1H), 7.9 (d, J= 9 Hz, 2H), 7.4 (d, J= 9 Hz, 2H), 7.1 (d, J=3.7 Hz, 
1H), 7.01 (d, J= 8.7 Hz, 2H), 6.97 (d, J= 16 Hz, 1H), 6.85 (d, J= 16 Hz, 
1H), 6.82 (d, J= 3.8 Hz, 1H), 6.7 (d, J= 8.9 Hz, 2H), 4.2 (t, J= 6 Hz, 2H), 
3.8 (t, J= 5.9 Hz, 2H), 3.5 (q, 2H), 1.3 (t, J= 7 Hz, 3H), 0.3 (s, 9H). 13C 
NMR (CDCl3): 190.7, 163.6, 147.2, 145.6, 133.4, 131.9, 130.19, 130.16, 
129.5, 127.9, 124.3, 120.2, 117.1, 114.7, 111.9, 99.4, 98.2, 65.8, 49.5, 
45.8, 12.3. 
4-[2-(Ethylphenyl-mino)ethoxy]phenol (2a): 2-[ethyl-
(phenyl)amino]ethanol (1) (3.00 g, 18.07 mmol), hydroquinone (3.98 g, 
36.14 mmol) and PPh3 (9.51 g, 36.14 mmol) were dissolved in THF (55 
mL). Air was removed by bubbling with argon for 20 min. A solution of 
DIAD (7.16 mL, 36.14 mmol) in THF (35 mL) was then added dropwise 
and the mixture was stirred overnight at room temperature. The solvent 
was removed in reduce pressure and the crude product was purified on 
column chromatography with CH2Cl2 to yield 1.68 g (36%). 1H NMR 
(CDCl3): 7.38 (q, 2H), 6.87 (m, 7H), 6.58 (s, 1H), 4.17 (t, J= 6.3 Hz, 2H), 
3.80 (t, J= 6.3 Hz, 2H), 3.59 (q, 2H), 1.31 (t, J= 6.9 Hz, 3H). 13C NMR 
(CDCl3): 152.6, 149.6, 147.4, 129.3, 116.1, 115.5, 111.9, 66.0, 49.6, 45.5, 
12.1. 
[[4-[Ethyl[2-(4-hydroxyphenoxy)ethyl]amino]phenyl]methyl]-
triphenylphosphonium iodide (2b): Compound 7 (0.600 g, 2.34 mmol), 
PPh3 (0.552 g, 2.34 mmol) and paraformaldehyde (0.063 g, 0.70 mmol) 
were dissolved in toluene (8 mL). NaI (0.434 g, 2.34 mmol), water (0.4 
mL) and acetic acid (1.2 mL) were then added. The solution was stirred 
for 66 h at 61 °C. Water (30 mL) was added and the mixture was stirred 
for 10 min. The aqueous layer was extracted with CH2Cl2 and the 
combined organic layers were washed with NaHCO3 (20 mL) and water 
(20 mL), dried and evaporated under reduced pressure. The crude 
product was washed with Et2O to afford 1.362 g of 2b (88%). 1H NMR 
(CDCl3): 7.64 (m, 15H), 7.05 (d, J= 8.7 Hz, 2H), 6.76 (m, 4H), 6.44 (d, 
J=8.7 Hz, 2H), 4.88 (d, J= 12.9 Hz, 2H), 4.05 (t, J=6.3 Hz, 2H), 3.77 
(s,1H), 3.71 (t, J=6.3 Hz, 2H), 3.48 (q, 2H), 1.22 (t, J=6.9 Hz, 3H). 13C 
NMR (DMSO-d6): 151.2, 151.0, 147.2 (d, J = 2.7 Hz), 134.8 (d, J = 2.9 
Hz), 133.9 (d, J = 9.7 Hz), 131.0 (d, J = 9.7 Hz), 129.9 (d, J = 12.2 Hz), 
118.1 (d, J = 84.7 Hz), 115.6, 115.2, 112.4 (d, J = 8.7 Hz), 111.5, 65.7, 
48.8, 44.5, 27.5 (d, J = 45.0 Hz), 11.6. 31P NMR (DMSO-d6): 21.1. 
4-[2-(Ethyl-[4-[2-(5-iodothiophen-2-yl)vinyl]phenyl]amino)ethoxy]-
phenol (4a): Air was removed from a mixture of 2b (2.09 g, 3.18 mmol), 
3 (0.556 g, 2.34 mmol) and tBuOK (0.53 g, 4.67 mmol) by bubbling with 
argon for 20 min. Fresh distilled CH2Cl2 (25 mL) was added. The solution 
was stirred at room temperature overnight, then filtered through a short 
pad of mixed celite and silica gel. The solvent was removed under 
reduce pressure, and the crude product was purified on column 
chromatography with mixed solvent CH2Cl2 to yield 0.62 g of Z/E 
stereoisomers (45/55). The mixture of isomers was then mixed with I2 in 
Et2O under beam of light to obtain 4a (54%). M.p: 114 °C. 1H NMR 
(CDCl3): 7.34 (d, J= 8.8 Hz, 2H), 7.11 (d, J= 3.8 Hz, 1H), 6.98 (d, J= 16 
Hz, 1H), 6.78 (d, J=16 Hz, 1H), 6.77 (d, J= 2.5 Hz, 4H), 6.71 (d, J= 9 Hz, 
2H), 6.64 (d, J= 3.8 Hz, 1H), 4.53 (s, 1H), 4.09 (t, J=6.3 Hz, 2H), 3.74 (t, 
J=6 Hz, 2H) 3.53 (q, 2H), 1.24 (t, J= 6.9 Hz, 3H). 13C NMR (CDCl3): 152.7, 
149.9, 149.7, 147.4, 137.4, 129.4, 127.8, 125.8, 124.4, 116.5, 116.1, 
115.5, 111.8, 70.3, 66.0, 49.6, 45.6, 12.3. 
Acetic acid 4-[2-(ethyl-[4-[2-(5-iodothiophen-2-yl)vinyl]phenyl]-
amino)ethoxy]phenyl ester (4b): Under argon, to a mixture of 4a (0.62 
g, 1.26 mmol) in CH2Cl2 (36 mL), DMAP (22 mg, 0.18 mmol) was added 
and stirred 5 min at 0°C. At 0°C, Et3N (0.39 mL) was then added and 
acetyl chloride (0.19 mL, 2.73 mmol) was added dropwise. The mixture 
was stirred overnight at room temperature. Ice was added in solution 
followed by NaHCO3sat (20 mL) and stirred 5 min. The organic layer was 
then extracted (3 × 15 mL), dried and concentrated under vacuum. The 
crude product was purified on column chromatography with CH2Cl2 to 
yield 0.61 g (97%) of 4b. 1H NMR (CDCl3): 7.34 (d, J= 8.7 Hz, 2H), 7.11 
(d, 3.7 Hz 1H), 7.01 (d, 9 Hz, 2H), 6.98 (d, J= 16 Hz, 1H), 6.89 (d, J= 9.3 
Hz, 2H), 6.78 (d, J= 16 Hz, 1H), 6.71 (d, J= 9 Hz, 2H), 6.64 (d, J= 4 Hz, 
1H). 13C NMR (CDCl3): 169.8, 156.3, 150.0, 147.3, 144.4, 137.4, 129.5, 
127.8, 125.8, 124.6, 122.4, 116.6, 115.0, 111.82, 111.8, 70.3, 65.8, 49.6, 
45.7, 12.3. 
Acetic acid 4-[2-(ethyl-[4-[2-(5-trimethylsilanylethynylthiophen-2-
yl)vinyl]phenyl]amino)ethoxy]phenyl ester (5): Air was removed from 
the solution of 4b (0.37 g, 0.70 mmol) dissolved in toluene (5 mL) and 
Et3N (1 mL) by bubbling with argon for 20 min. After heating at 40 °C, CuI 
(3 mg, 0.02 mmol), Pd(PPh3)2Cl2 (12 mg, 0.02 mmol) and 
ethynyltrimethylsilane (0.19 mL, 1.31 mmol) were added. The mixture 
was stirred at 40 °C overnight. Solvent was removed by reduce pressure 
and the crude product was purified by column chromatography with 
CH2Cl2/ Heptane (6:4 ) to yield 0.33 g (94%) of 5. 1H NMR (CDCl3): 7.37 
(d, J= 9 Hz, 2H), 7.12 (d, J= 3.9 Hz, 1H), 7.03 (d, J=9 Hz, 2H), 6.98 (d, 
J= 16 Hz, 1H), 6.90 (d, J= 9 Hz, 2H), 6.87 (d, J= 16 Hz, 1H), 6.83 (d, J= 
3.9 Hz, 1H), 6.72 (d, J= 9 Hz, 2H), 4.13 (t, J= 6 Hz, 2H), 3.77 (t, J= 5.9 
Hz, 2H), 3.54 (q, 2H), 2.29 (s, 3H), 1.26 (t, J= 6.9 Hz, 3H), 0.30 (s, 9 Hz). 
13C NMR (CDCl3): 169.7, 156.11, 156.09, 147.2, 145.5, 144.14, 144.11, 
142.2, 133.2, 132.2, 130.6, 129.9, 129.5, 127.7, 127.2, 124.0, 122.17, 
122.15, 119.9, 119.7, 116.7, 114.8, 111.6, 111.2, 99.1, 98.0, 65.6, 49.42, 
49.39, 45.5, 45.4, 31.7, 31.28, 31.22, 29.97, 29.91, 29.48, 29.45, 29.41, 
29.29, 29.15, 28.9, 28.7, 22.5, 20.8, 13.9, 12.1. 
4-[2-[[4-[(1E)-2-[5-[(9,9-dibutyl-7-iodo-9H-fluoren-2-yl)ethynyl]2-
thienyl]ethenyl]phenyl]ethylamino]ethoxy]benzaldehyde (9a): Air 
was removed from a mixture of 8 (0.63 g, 1.34 mmol), 9,9-dibutyl-2,7-
diiodo-9H-fluorene 9 (2.13 g, 4.01 mmol) and Et3N (2.4 mL) dissolved in 
toluene (12 mL) by bubbling with argon for 20 min. After heating at 40°C, 
CuI (5.7 mg, 0.03 mmol) and Pd(PPh3)2Cl2 (21 mg, 0.03 mmol) were 
added. Air was removed from the solution of TBAF in THF (1 M, 0.80 
mmol) by blowing argon for 5 min and then added to the mixture. The 
solution was stirred overnight at 40 °C. Solvent was removed by reduce 
pressure and the crude product was purified by column chromatography 
with mixed solvent CH2Cl2/Heptane (6:4) to yield 0.83 g (77%) of orange 
crystals of compound 9a. M.p: 146 °C. 1H NMR (CDCl3): 9.89 (s, 1H), 
7.85 (d, J= 8.9 Hz, 2H), 7.68 (dd, J= 1.6 Hz, 1H), 7.66 (s, 1H), 7.63 (d, J= 
8.6 Hz, 1H), 7.51 (dd, J= 1.4 Hz, 1H), 7.46 (s, 1H), 7.42 (d, J= 8.4 Hz, 
1H), 7.39 (d, J= 9 Hz, 2H), 7.18 (d, J= 3.6 Hz, 1H), 7.01 (d, J= 8.7 Hz, 
2H), 6.96 (d, J= 16 Hz, 1H), 6.90 (d, J= 3.3 Hz, 1H), 6.89 (d, J= 15.3 Hz, 
1H), 6.73 (d, J= 9 Hz, 2H), 4.25 (t, J= 6.3 Hz, 2H), 3.83 (t, J= 5.7 Hz, 2H), 
3.56 (q, 2H), 1.96 (m, 4H), 1.26 (t, J= 7.2 Hz, 3H), 1.14 (q, 4H), 0.72 (t, 
J= 7.2 Hz, 6H), 0.56 (m, 4H). 13C NMR (CDCl3): 190.6, 163.4, 153.2, 
150.0, 147.0, 145.5, 140.2, 139.8, 135.8, 132.5, 131.87, 131.82, 130.3, 
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129.9, 129.3, 127.8, 125.4, 124.7, 124.6, 121.7, 121.5, 120.2, 119.6, 
116.9, 114.5, 111.7, 94.6, 92.9, 83.7, 65.6, 55.1, 49.3, 45.6, 39.9, 29.5, 
25.7, 22.8, 13.6, 12.2. HRMS (ESI) calcd for C46H46NO2INaS [(M+Na)+] 
m/z 826.21862, found 826.2185. 
4-[2-[[4-[(1E)-2-[5-[2-[9,9-dibutyl-7-[2-[5-[(1E)-2-[4-[ethyl-[2-[4-
(formyl)phenoxy]ethyl]amino]phenyl]ethenyl]-2-thienyl]ethynyl]-9H-
fluoren-2-yl]ethynyl]-2-thienyl]ethenyl]phenyl]ethylamino]ethoxy]-
phenyl acetate (9b): Air was removed from 5 (0.33 g, 0.66 mmol), the 
previous compound 9a (0.48 g, 0.60 mmol) and Et3N (2.8 mL) dissolved 
in toluene (14 mL) by bubbling with argon for 20 min. After heating at 
40°C, CuI (2.3 mg, 12 µmol) and Pd(PPh3)2Cl2 (8.4 mg, 12 µmol) were 
added. Air was removed from the solution of TBAF in THF (1 M, 0.42 
mmol) by blowing argon for 5 min and then added to the mixture. The 
solution was stirred overnight at 40 °C. Solvent was removed by reduce 
pressure and the crude product was purified by column chromatography 
with mixed solvent CH2Cl2/Heptane (7:3) to yield 0.46 g (70%) of orange 
crystals of compound 9b. M.p: 160 °C. 1H NMR (CDCl3): 9.89 (s, 1H), 
7.85 (d, J= 9 Hz, 2H), 7.68 (d, J=8.6 Hz, 2H), 7.52 (m, 4H), 7.39 (dd, J=3 
Hz, 4H), 7.19 (d, J=4 Hz, 2H), 7.02 (d, J= 16 Hz, 2H), 7.01 (d, J= 9 Hz, 
2H), 6.90 (s, 4H), 6.89 (s, 2H), 6.85 (d, J=16 Hz, 2H), 6.74 (dd, J=3 Hz, 
4H), 4.24 (t, J=6 Hz, 2H), 4.14 (t, J=6 Hz, 2H), 3.82 (m, 4H), 3.53 (qd, 
4H), 2.29 (s, 3H), 2.03 (m, 4H), 1.28 (td, J= 3.9 Hz, 6H), 1.16 (m, 4H), 
0.73 (t, J= 7.2 Hz, 6H), 0.63 (m, 4H). 13C NMR (CDCl3): 190.9, 170.0, 
163.8, 156.4, 151.2, 145.8, 144.5, 132.8, 132.2, 130.6, 130.3, 129.8, 
128.1, 125.83, 125.76, 125.0, 124.0, 124.81, 124.77, 122.5, 120.6, 120.1, 
117.3, 115.2, 114.9, 111.9, 65.94, 65.92, 55.3, 49.8, 49.62, 49.60, 45.96, 
45.86, 26.0, 23.2, 21.1, 13.9, 12.5. HRMS (ESI) calcd for 
C72H70N2O5NaS2 [(M+Na)+] m/z 1129.46184, found 1129.4620. 
Photosensitizer 10: The compound 9b (0.46 g, 0.42 mmol) was 
dissolved in a mixture of EtOH (10 mL) and THF (28 mL). NaOH (4 mL) 
was then added and the solution was stirred 20 min at room temperature, 
and HCl (15 mL) was added. Aqueous layer was extracted with CH2Cl2 
(10 mL), and organic layer was then washed with water (5 mL). The 
organic layer was dried and concentrated under vacuum. The crude 
product was purified on column chromatography with CH2Cl2 to yield 0.37 
g (84%) of orange crystals of 10. M.p: 94 °C. 1H NMR (CDCl3): 9.89 (s, 
1H), 7.85 (d, J= 9 Hz, 2H), 7.68 (d, J=8.6 Hz, 2H), 7.52 (m, 4H), 7.39 (dd, 
J=3 Hz, 4H), 7.19 (d, J=4 Hz, 2H), 7.01 (d, J= 9 Hz, 2H), 6.99 (2×d, J= 16 
Hz, 2H), 6.89 (m, 2H), 6.87 (d, J=16 Hz, 2H), 6.77 (s, 4H), 6.74 (dd, J=3 
Hz, 4H), 5.19 (s, 1H), 4.24 (t, J=6 Hz, 2H), 4.10 (t, J=6 Hz, 2H), 3.82 (t, 
J= 5.7 Hz, 2H), 3.73 (t, J=5.7 Hz, 2H), 3.53 (m, 4H), 2.01 (m, 4H), 1.28 
(2×t, J= 3.9 Hz, 6H), 1.16 (m, 4H), 0.73 (t, J= 7.2 Hz, 6H), 0.63 (m, 4H). 
13C NMR (CDCl3): 191.1, 163.8, 152.8, 151.2, 149.9, 147.6, 147.3, 145.9, 
145.8, 140.76, 140.71, 132.77, 132.16, 130.6, 130.1, 129.8, 129.6, 
128.04, 128.01, 125.7, 124.93, 124.86, 124.7, 124.6, 121.83, 121.77, 
120.5, 120.3, 120.1, 117.2, 116.9, 116.1, 115.6, 114.8, 111.9, 111.8, 
105.0, 95.0, 84.07, 84.01, 66.1, 65.9, 55.3, 49.8, 49.5, 45.9, 45.7, 40.3, 
25.9, 23.1, 13.9, 12.43, 12.40. HRMS (ESI) calcd for C70H69N2O4S2 
[(M+H)+] m/z 1065.46933, found 1065.4691. ATR-FTIR (cm-1): 3363, 
2926, 2189, 2037, 1685, 1596, 1507, 1446, 1397, 1349, 1256, 1221, 
1182, 1158, 1136, 1074, 1020, 946, 885, 806, 751. 
4-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]phenol (12). In a solution of 
triethylene glycol monomethyl ether (6.00 g, 36.58 mmol) in CH2Cl2 (10 
mL) at 0°C, was added Et3N (5.83 mL). The mixture was cooled below 
5°C. Stirring vigorously and maintaining the reaction mixture at that 
temperature, a solution of p-toluenesulfonyl chloride (3.25 mL; 42.07 
mmol) in 3mL of CH2Cl2 was added dropwise. Stirring was continued 
overnight at room temperature. A white precipitate was filtered and the 
filtrate was washed with NaHCO3 (2 × 10mL). The aqueous layer was 
extracted with CH2Cl2. Organic layers were combined, dried over Na2SO4 
then evaporated under reduce pressure to yield 8.46 g (95%) of yellow oil. 
In a solution of this oil (8.46 g, 34.97 mmol) in 25 mL of DMSO, was 
added hydroquinone (3.86 g, 34.97 mmol), and KOH (5.89 g, 104.91 
mmol). The mixture was stirred overnight at room temperature (water 
bath) and 20 mL of water was then added. The solution was extracted (3 
× 30 mL) with Et2O to remove both unreacted tosylate and disubstituted 
byproduct. The solution was then acidified with concentrated HCl and 
extracted with CHCl3 (3 × 20 mL). The combined organic layers were 
washed with water until neutrality, dried over Na2SO4, and concentrated 
in vacuo to yield 3.69 g (41%) of brown oil of 12. 1H NMR (CDCl3): 6.82 
(s, 1H), 6.73 (d, J = 9 Hz, 2H), 6.69 (d, J = 9 Hz, 2H), 3.98 (t, J = 4.8 Hz, 
2H), 3.79 (t, J = 4.8 Hz, 2H), 3.70 (m, 6H), 3.55 (m, 2H), 3.34 (s, 3H). 13C 
NMR (CDCl3): 152.3, 150.1, 115.9, 115.5, 71.7, 70.5, 70.4, 70.3, 69.7, 
67.8, 58.8. HRMS (ESI) calcd for C13H20N2O5Na [(M+Na)+] m/z 
279.12029, found 279.1203. ATR-FTIR (cm-1): 3333.3, 2873.0, 1508.4, 
1448.9, 1355.7, 1214.9, 1096.0, 1064.3, 824.4, 753.1. 
Dendrimer 2-G1. The reaction was shielded from the light. To a solution 
of photosensitizer 10 (152 mg, 142.72 mol) in distilled THF (0.75 mL) 
was added Cs2CO3 (93 mg, 285.43 mol). The solution was stirred 2h at 
35°C. A solution of dendrimers bearing P(S)Cl2 1-G1 (20 mg, 10.95 mol) 
in 0.75 mL of distilled THF was then added and stirred 7days at 35°C. 
The reaction was monitored by 31P using a C6D6 capillary. The resulting 
mixture was filtered and dendrimer was precipitated in pentane (200 mL). 
The orange precipitate was purified on column chromatography 
(pentane: THF: 1:1 until THF 100%) and washed several times with 
AcOEt, to eliminate the excess of 10, and dried under reduce pressure to 
yield 106 mg (69%) of orange powder. Mp: 178 °C.1H NMR (CD2Cl2) 9.86 
(s, 12H), 7.82 (d, J = 8.7 Hz, 24H), 7.67 (dd, J = 7.8 Hz, 24H), 7.59 (m, 
66H), 7.36 (d, J = 9 Hz, 24H), 7.30 (d, J = 8.4 Hz, 24H), 7.16 (dd, J = 3.9 
Hz, 24H), 7.05 (m, 132 H), 6.73 (d, J = 8.7 Hz, 48H), 6.64 (d, J = 7.5 Hz, 
24H), 4.24 (t, J = 6 Hz, 24H), 3.98 (t, J = 6 Hz, 24H), 3.80 (t, J = 6 Hz, 
24H), 3.62 (s br, 24H), 3.54 (q, 24H), 3.40 (s br, 24H), 3.21 (d, J = 12 Hz, 
18H), 2.00 (m, 48H), 1.21-1,02 (m, 120H), 0.77-0.48 (m, 120H). 13C NMR 
(CD2Cl2) 191.42, 164.63, 157.13, 152.18, 148.45, 146.77, 145.22, 141.67, 
133.73, 132.72, 131.31, 131.16, 130.59, 128.82, 126.64, 125.77, 123.22, 
122.68, 122.25, 121.19, 121.00, 117.70, 115.97, 115.65, 112.84, 95.75, 
84.76, 84.67, 66.95, 61.16, 56.14, 55.08, 54.72, 54.36, 50.39, 46.68, 
41.03, 34.00, 31.01, 26.92, 23.99, 14.93, 14.57, 13.01. 31P (CDCl3), 
64.40, 8.63. LC/MS: calcd avg mass for C888H852N39O54NaP9S30 
[(M+Na)+] m/z 14198.2 found: 14197.1. 
Dendrimer 1-G2. The reaction was shielded from the light. 2-G1 (86.4 mg, 
6.10 mol) was cooled at 0 °C and 11 (508.3 L, 91.5 mol) in solution in 
CHCl3 was added. The solution was stirred 5 days at room temperature 
(monitored by 1H NMR). Dendrimer was precipitated in pentane (200 mL), 
to remove excess of 11, filtered under argon then dried under reduce 
pressure to yield 85 mg (86%) of orange powder. M.p: 184 °C.1H NMR 
(CDCl3) 7.68 (m, 120H), 7.38 (d, J = 8.4 Hz, 24H), 7.31 (d, J = 8.4 Hz, 
24H), 7.16 (dd, J = 3.7 Hz, 24H), 7.06- 6.63 (m, 192 H), 4.19 (t, J = 4.5 
Hz, 24H), 3.96 (s br, 24H), 3.80 (s br, 24H), 3.62 (s br, 24H), 3.53 (m, 
84H), 3.19 (d, J = 9.6 Hz, 18H), 1.98 (m, 48H), 1.15 (m, 120H), 0.69 (m, 
120H). 13C NMR (CDCl3): 160.31, 156.04, 151.50, 151.11, 147.34, 
145.72, 144.23, 141.71, 140.65, 135.75, 132.68, 130.52, 129.56, 128.95, 
128.23, 127.95, 127.19, 125.59, 125.50, 124.72, 124.58, 122.29, 121.73, 
121.37, 120.41, 120.33, 120.02, 117.08, 116.95, 115.03, 114.75, 111.84, 
94.92, 83.94, 65.75, 65.56, 55.17, 49.58, 45.76, 45.63, 40.18, 34.21, 
33.07, 31.75, 30.31, 25.90, 23.05, 21.18, 13.85, 12.34, 12.31. 31P 
(CDCl3) 64.41, 63.30, 8.66. 
Dendrimer 2-G2. The reaction was shielded from the light. To a solution 
of 12 (12 mg, 46.50 mol) in distilled THF (2mL), was added Cs2CO3 (29 
mg, 89.28 mol) and stirred overnight at room temperature. 1-G2 (30.1 
mg, 1.86 mol) in 1.5 mL of distilled THF was then added to the mixture 
and stirred 5 days at room temperature. (monitored by 31P NMR). The 
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solution was filtered, and dendrimer was precipitated in pentane (200 
mL). The resulting powder was washed with Et2O to removed excess of 
12 then solubilized in THF and centrifuged to remove cesium traces. 
Dendrimer was again precipitated in pentane, filtered under argon, and 
dried under reduce pressure to yield 30 mg (75%) of orange powder. 
M.p: 178 °C.1H NMR (CDCl3) 7.68-7.28 (m, 168H), 7.13-6.52 (m, 317H), 
4.16-3.16 (m, 558H), 1.97 (m, 48H), 1.11 (m, 120H), 0.66 (m, 120H). 31P 
(CDCl3) 64.59, 8.61. 
Photophysical studies 
UV-Vis absorption and emission spectroscopy. All photophysical 
measurements have been performed with freshly-prepared solutions in 
air-equilibrated THF at room temperature (298 K). UV/Vis absorption 
spectra were recorded on a Jasco V-570 spectrophotometer. Steady-
state and time-resolved fluorescence measurements were performed on 
dilute solutions (ca. 10-6 M chromophore concentration, optical density < 
0.1) contained in standard 1 cm quartz cuvettes using an Edinburgh 
Instruments (FLS920) spectrometer in photon-counting mode. Emission 
spectra were obtained, for each compound, under excitation at the 
wavelength of the absorption maximum. Fluorescence quantum yields 
were measured according to literature procedures using quinine bisulfate 
in 0.5 M H2SO4 as a standard (quantum yield  = 0.546).[38] The lifetime 
values were obtained from the reconvolution fit analysis (Edinburgh F900 
analysis software) of decay profiles obtained using the FLS920 
instrument under excitation with a nitrogen-filled nanosecond flash-lamp. 
The quality of the fits was evidenced by the reduced ² value (² <1.1). 
Measurements of singlet oxygen quantum yield (). Measurements 
were performed on a Fluorolog-3 (Horiba Jobin Yvon), using a 450 W 
Xenon lamp. The emission at 1272 nm was detected using a liquid 
nitrogen-cooled Ge-detector model (EO-817L, North Coast Scientific Co). 
Singlet oxygen quantum yields  were determined in dichloromethane 
solutions, using tetraphenylporphyrin (TPP) in dichloromethane as 
reference solution ([TPP] = 0.60) and were estimated from 1O2 
luminescence at 1272 nm. 
Two-photon absorption. Two-photon absorption cross sections (2) were 
obtained from the two-photon excited fluorescence (2PEF) cross sections 
(2) and the fluorescence emission quantum yield (). 2PEF cross 
sections in toluene (10-4 M chromophore concentration) were determined 
using a Ti-sapphire laser delivering 150 fs excitation pulses, according to 
the experimental protocol established by Xu and Webb.[39] This 
experimental protocol allows avoiding contributions from excited-state 
absorption that are known to result in largely overestimated 2PA cross-
sections. Fluorescein in 0.01 M NaOH, whose 2PEF cross-sections are 
well-known,[39] served as the reference, taking into account the 
necessary corrections for the refractive index of the solvents.[40] The 
quadratic dependence of the fluorescence intensity on the excitation 
intensity was verified for each data point, indicating that the 
measurements were carried out in intensity regimes in which saturation 
or photodegradation do not occur. More details about the experimental 
setup have been previously published.[31] 
Cellular imaging. One- and two-photon imaging have been performed 
on Montpellier RIO Imaging (MRI) platform. For cell culture, MCF-7 
human breast cancer cells (ATCC) were routinely cultured in Dulbecco's 
Modified Eagle Medium F-12 Nutrient Mixture (Ham) supplemented with 
glutamax, 10% foetal bovine serum, and 1/100 antibiotics (penicillin/ 
streptomycin). Cells were allowed to grow in humidified atmosphere at 
37°C under 5% CO2. On the one hand, cells were incubated 24 h with 
dendrimer 2-G2 (50 µg.mL-1). Thirty minutes before the end of incubation, 
cells were loaded with 2 µg.mL-1 Hoechst 33342 for nuclear staining. 
After 30 min cells were washed and maintain in fresh culture medium 
without serum and phenol red. For confocal imaging, a Zeiss LSM 780 
microscope equipped with DIC plan-apochromat 63x/1.4 NA oil 
immersion objective was used. Nuclear staining was excited at 405 nm 
and 2-G2 at 548 nm. On the other hand, cells were incubated 3 h with 
dendrimer 2-G2 (50 µg/ml). Thirty minutes before the end of incubation, 
cells were loaded with 1 mg.mL-1 CellMask for plasma membrane stains. 
For multi-photon imaging, a Zeiss LSM 780 microscope with tuneable 
Chameleon Ultra II laser (Coherent, mode- locked Ti: sapphire laser, 
680-1080 nm) and equipped with DIC plan-apochromat 63x/1.4 NA oil 
immersion objective was used. 2-G2 and plasma membrane stains were 
excited at 750 nm. 
Two-photon excited photodynamic therapy. For experiments of 2PE-
PDT, MCF-7 breast cancer cells were seeded in a 384 multi-well plate 
with 0.17 mm glass bottom and incubated with or without 2-G2 (50 g. 
mL-1) for 20 hours. After incubation, cells were washed, maintained in 
fresh culture medium and then submitted or not to laser irradiation. Two-
photon irradiation was carried out on MRI platform. PDT was then 
performed on a multi-photon confocal microscope Zeiss LSM 780 
equipped with tuneable Chameleon Ultra II laser (Coherent, 680-1080 
nm) generating 140 fs wide pulses at 80 MHz rate. The laser beam was 
focused by a microscope objective lens (10x, NA 0.4). The wells were 
irradiated at 760 nm by 3 scans of 1.57 sec each at an average power of 
80 mW. The surface of the scanned areas was 1.5 x 1.5 mm2 (mean 
energy of 16.6 J cm-2). Two days after irradiation, the percentage of living 
cells was determined by MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl) -2-(4sulfophenyl)-2H-tetrazolium) enzymatic 
assay. Briefly, cells were incubated in the presence of 0.5 mg. mL-1 MTS 
for 4 h to determine mitochondrial enzyme activity. Absorbance was read 
at 492 nm with a spectrophotometer Thermoscientific Multiskan FC. 
Daylight study. For experiments of daylight toxicity, MCF-7 cancer cells 
were seeded in a 96 multi-well plate and incubated with or without 2-G2 
(20 g. mL-1) for 5 hours. 2-G2 was previously solubilized in THF at 5 
mg/mL and sonicated. After incubation, cells were washed, maintained in 
fresh culture medium and then submitted or not to daylight for 4 hours. 
The percentage of living cells was determined by MTT (3-(4,5-
dimethylthizol-2-yl)-2,5-diphenyltetrazolium bromide) enzymatic assay. 
Briefly, cells were incubated in the presence of 0.5 mg. mL-1 MTT for 4 
hours to determine mitochondrial enzyme activity. Then medium was 
removed and purple precipitate was dissolved in 150 l ethanol/DMSO 
(1:1) solution and stirred 30 min. Then absorbance was read at 540 nm. 
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New dendrimers combining large two-photon brightness and photosensitizing 
properties are efficient cell death inducers under two-photon irradiation in the NIR, 
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